Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The workshop was organized by the Department of Urology as a first step to enabling government medical colleges in Rajasthan to offer the latest surgical technology
The plant is expected to start commercial operations from Q4FY24
Essent continues to broaden its highly characterized, low passage primary cell catalog
The science leader comes with a rich experience in the employment testing industry
Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients
There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022
The team built a multiple ionic device system, each of which had a lithium cobalt oxide channel arranged on a common lithium phosphorus oxynitride electrolyte
Subscribe To Our Newsletter & Stay Updated